Loading patent…
AssigneeBio Merieux
InventorsFrederic Beseme, Jean-Luc Blond, Olivier Bouton, Bernard Mandrand, Francois Mallet, Herve Perron
Estimating the term…
The invention concerns a genomic retroviral nucleic material, in an isolated or purified state, at least partially functional or non-functional, wherein the genome comprises a reference nucleotide sequence selected from the group including sequences of SEQ ID NOs: 1-15, their complementary sequences, and their equivalent sequences, in particular, nucleotide sequences having, for every series of 100 contiguous monomers, at least 70% and preferably at least 90% homology with the sequences of SEQ ID NOs: 1-15. The invention also concerns the application of this material.
A nucleic material, in an isolated or purified state, comprising a nucleotide sequence selected from the group consisting of sequences of SEQ ID NOs:
A nucleic material, in an isolated or purified state, comprising a nucleotide sequence, encoding any polypeptide exhibiting, for every contiguous sequence of at least 30 amino acids, at least 80% identity with a peptide sequence encoded by at least a functional part of a nucleotide sequence selected from the group consisting of sequences of SEQ ID NOs:
A nucleic material consisting of a nucleotide sequence identical to SEQ ID NO:
A nucleotide fragment comprising a nucleotide sequence selected from the group consisting of:
A nucleic probe or nucleic primer, comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:
Dependencies are inferred from the claim text.